Russell Investments Group Ltd. grew its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 61.7% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 569,749 shares of the real estate investment trust's stock after buying an additional 217,500 shares during the quarter. Russell Investments Group Ltd. owned 0.24% of Sabra Healthcare REIT worth $9,954,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Northern Trust Corp lifted its stake in Sabra Healthcare REIT by 27.7% during the fourth quarter. Northern Trust Corp now owns 4,169,385 shares of the real estate investment trust's stock worth $72,214,000 after purchasing an additional 905,466 shares during the last quarter. Bank of New York Mellon Corp lifted its stake in Sabra Healthcare REIT by 1.8% during the first quarter. Bank of New York Mellon Corp now owns 4,114,215 shares of the real estate investment trust's stock worth $71,875,000 after purchasing an additional 74,564 shares during the last quarter. Nuveen LLC purchased a new stake in Sabra Healthcare REIT during the first quarter worth approximately $61,791,000. Janus Henderson Group PLC lifted its stake in Sabra Healthcare REIT by 23.1% during the fourth quarter. Janus Henderson Group PLC now owns 3,504,809 shares of the real estate investment trust's stock worth $60,720,000 after purchasing an additional 657,950 shares during the last quarter. Finally, Nuveen Asset Management LLC lifted its stake in Sabra Healthcare REIT by 30.8% during the fourth quarter. Nuveen Asset Management LLC now owns 3,378,733 shares of the real estate investment trust's stock worth $58,520,000 after purchasing an additional 795,902 shares during the last quarter. Hedge funds and other institutional investors own 99.40% of the company's stock.
Wall Street Analyst Weigh In
SBRA has been the subject of several recent analyst reports. Scotiabank boosted their target price on Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a research note on Monday, June 23rd. JMP Securities boosted their target price on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a research note on Wednesday, August 6th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $20.00.
Get Our Latest Research Report on Sabra Healthcare REIT
Sabra Healthcare REIT Stock Performance
Sabra Healthcare REIT stock traded down $0.07 during midday trading on Friday, hitting $19.55. 3,551,550 shares of the company's stock were exchanged, compared to its average volume of 2,798,686. Sabra Healthcare REIT, Inc. has a 12-month low of $15.60 and a 12-month high of $20.03. The company has a debt-to-equity ratio of 0.91, a quick ratio of 4.80 and a current ratio of 4.80. The stock has a market cap of $4.69 billion, a price-to-earnings ratio of 25.72, a price-to-earnings-growth ratio of 1.56 and a beta of 0.86. The firm's 50 day simple moving average is $18.45 and its 200 day simple moving average is $17.70.
Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.02. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The company had revenue of $189.15 million for the quarter, compared to the consensus estimate of $185.64 million. During the same period last year, the firm posted $0.36 EPS. Sabra Healthcare REIT's revenue for the quarter was up 7.4% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. Equities research analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.
Sabra Healthcare REIT Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 29th. Shareholders of record on Friday, August 15th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 6.1%. The ex-dividend date of this dividend is Friday, August 15th. Sabra Healthcare REIT's dividend payout ratio (DPR) is presently 157.89%.
Sabra Healthcare REIT Company Profile
(
Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
See Also
Before you consider Sabra Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.
While Sabra Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
